Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-101955
Filing Date
2022-09-21
Accepted
2022-09-21 16:39:52
Documents
2
Period of Report
2022-09-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2226340-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2226340-5_3seq1.xml 3 15358
2 EXHIBIT 24.1 tm2226340d5_ex24-1.htm EX-24.1 8438
  Complete submission text file 0001104659-22-101955.txt   25174
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VOYAGER THERAPEUTICS, INC. 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Carter Todd Alfred (Reporting) CIK: 0001944011 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37625 | Film No.: 221256770